A Ceritinib dihydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Ceritinib dihydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Ceritinib dihydrochloride DMFs exist exist since differing nations have different regulations, such as Ceritinib dihydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ceritinib dihydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Ceritinib dihydrochloride USDMF includes data on Ceritinib dihydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ceritinib dihydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ceritinib dihydrochloride suppliers with USDMF on PharmaCompass.